Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Post by enriquesuaveon Nov 30, 2021 9:19pm
570 Views
Post# 34183166

PR patients

PR patients We have 2 PR patients at 450 days. IMO there is a high chance that they are CR, as if they have been PR for so long, then positive cytology could very well be coming from Ureter and not bladder.  Why do I highly suspect that this is the case, well if cancer was present in the bladder, but undetected by Cystoscope at 180 or 270 days, then most probably by day 450 CIS would be visible with cystoscope.  Since it is not, then I suspect high chance that bladders are CR and UTUC is the culprit in showing a positive cytology report.  All speculation on my part so don't take my word for it. I'm guessing that they will soon do an MRI to inspect ureters of pass a scope to determine final verdict on these PR patients.All IMO 
<< Previous
Bullboard Posts
Next >>